L. Martin-carbonero, Y. Benhamou, M. Puoti, J. Berenguer, J. Mallolas et al., Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus???Infected Patients with Chronic Hepatitis C: A European Collaborative Study, Clinical Infectious Diseases, vol.38, issue.1, pp.128-133, 2003.
DOI : 10.1086/380130

S. Mehta, D. Thomas, M. Torbenson, S. Brinkley, L. Mirel et al., The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection, Hepatology, vol.284, issue.1, pp.123-131, 2005.
DOI : 10.1002/hep.20541

N. Qurishi, C. Kreuzberg, G. Luchters, W. Effenberger, B. Kupfer et al., Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection, The Lancet, vol.362, issue.9397, pp.3621708-1713, 2003.
DOI : 10.1016/S0140-6736(03)14844-1

G. Lauer and B. Walker, Hepatitis C Virus Infection, New England Journal of Medicine, vol.345, issue.1, pp.41-52, 2001.
DOI : 10.1056/NEJM200107053450107

C. Graham, L. Baden, E. Yu, J. Mrus, J. Carnie et al., Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta???Analysis, Clinical Infectious Diseases, vol.33, issue.4, pp.562-569, 2001.
DOI : 10.1086/321909

J. Macias, V. Castellano, N. Merchante, R. Palacios, J. Mira et al., Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C, AIDS, vol.18, issue.5, pp.767-774, 2004.
DOI : 10.1097/00002030-200403260-00007

A. Mohsen, P. Easterbrook, C. Taylor, B. Portmann, R. Kulasegaram et al., Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients, Gut, vol.52, issue.7, pp.521035-1040, 2003.
DOI : 10.1136/gut.52.7.1035

V. Soriano, L. Martin-carbonero, J. Garcia-samaniego, and M. Puoti, Mortality Due to Chronic Viral Liver Disease among Patients Infected with Human Immunodeficiency Virus, Clinical Infectious Diseases, vol.33, issue.10, pp.1793-1795, 2001.
DOI : 10.1086/323009
URL : http://cid.oxfordjournals.org/cgi/content/short/33/10/1793

H. Thein, Q. Yi, G. Dore, and M. Krahn, Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis, AIDS, vol.22, issue.15, pp.221979-1991, 2008.
DOI : 10.1097/QAD.0b013e32830e6d51

I. Bica, B. Mcgovern, R. Dhar, D. Stone, K. Mcgowan et al., Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection, Clinical Infectious Diseases, vol.32, issue.3, pp.492-497, 2001.
DOI : 10.1086/318501

M. Sulkowski, S. Mehta, M. Torbenson, N. Afdhal, L. Mirel et al., Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus, AIDS, vol.19, issue.6, pp.585-592
DOI : 10.1097/01.aids.0000163935.99401.25

S. Pol, P. Lebray, and A. Vallet-pichard, HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms, Clinical Infectious Diseases, vol.38, issue.Supplement 2, pp.65-72, 2004.
DOI : 10.1086/381499

R. Sterling, M. Contos, P. Smith, R. Stravitz, V. Luketic et al., Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection, Hepatology, vol.36, issue.4, pp.1118-1127, 2008.
DOI : 10.1002/hep.22134

F. Bani-sadr, F. Carrat, P. Bedossa, L. Piroth, P. Cacoub et al., Hepatic steatosis in HIV???HCV coinfected patients: analysis of risk factors, AIDS, vol.20, issue.4, pp.525-531, 2006.
DOI : 10.1097/01.aids.0000210606.63138.f5

I. Gaslightwala and E. Bini, Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection, Journal of Hepatology, vol.44, issue.6, pp.1026-1032, 2006.
DOI : 10.1016/j.jhep.2006.02.009

K. Marks, L. Petrovic, A. Talal, M. Murray, R. Gulick et al., Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus, The Journal of Infectious Diseases, vol.192, issue.11, pp.1943-1949, 1942.
DOI : 10.1086/497608

A. Monto, L. Dove, A. Bostrom, S. Kakar, P. Tien et al., Hepatic steatosis in HIV/hepatitis C coinfection: Prevalence and significance compared with hepatitis C monoinfection, Hepatology, vol.40, issue.2, pp.310-316, 2005.
DOI : 10.1002/hep.20805

B. Mcgovern, J. Ditelberg, L. Taylor, R. Gandhi, K. Christopoulos et al., Hepatic Steatosis Is Associated with Fibrosis, Nucleoside Analogue Use, and Hepatitis C Virus Genotype 3 Infection in HIV???Seropositive Patients, Clinical Infectious Diseases, vol.43, issue.3, pp.43365-372, 2006.
DOI : 10.1086/505495

D. Neau, M. Winnock, L. Castera, B. Bail, M. Loko et al., Prevalence of and Factors Associated With Hepatic Steatosis in Patients Coinfected With Hepatitis C Virus and HIV, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.45, issue.2, pp.45168-173, 2007.
DOI : 10.1097/QAI.0b013e318042e1db

M. Sanchez-conde, J. Berenguer, P. Miralles, F. Alvarez, C. Lopez et al., Liver biopsy findings for HIVinfected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase, Clin Infect Dis, issue.5, pp.43640-644, 2006.

L. Castera, M. Loko, L. Bail, B. Coffie, P. et al., Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype, Alimentary Pharmacology & Therapeutics, vol.19, issue.11-12, pp.11-121489, 2007.
DOI : 10.1111/j.1365-2036.2007.03533.x
URL : https://hal.archives-ouvertes.fr/inserm-00177055

V. Borghi, M. Puoti, C. Mussini, S. Bellelli, C. Angeletti et al., HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3, Antivir Ther, issue.8, pp.131057-1065, 2008.

A. Monto, J. Alonzo, J. Watson, C. Grunfeld, and T. Wright, Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol, Hepatology, vol.157, issue.3, pp.729-736, 2002.
DOI : 10.1053/jhep.2002.35064

A. Sanyal, Review article: non-alcoholic fatty liver disease and hepatitis C - risk factors and clinical implications, Alimentary Pharmacology and Therapeutics, vol.116, issue.1, pp.48-51, 2005.
DOI : 10.1002/hep.510300604

L. Hourigan, G. Macdonald, D. Purdie, V. Whitehall, C. Shorthouse et al., Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis, Hepatology, vol.29, issue.4, pp.1215-1219, 1999.
DOI : 10.1002/hep.510290401

K. Hu, N. Kyulo, E. Esrailian, K. Thompson, R. Chase et al., Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States, Journal of Hepatology, vol.40, issue.1, pp.147-154, 2004.
DOI : 10.1016/S0168-8278(03)00479-3

A. Sanyal, M. Contos, R. Sterling, V. Luketic, M. Shiffman et al., Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome, The American Journal of Gastroenterology, vol.116, issue.9, pp.982064-2071, 2003.
DOI : 10.1002/hep.510300604

K. Brinkman, Editorial Response: Hyperlactatemia and Hepatic Steatosis as Features of Mitochondrial Toxicity of Nucleoside Analogue Reverse Transcriptase Inhibitors, Clinical Infectious Diseases, vol.31, issue.1, pp.167-169, 2000.
DOI : 10.1086/313921

A. Balasubramanyam, R. Sekhar, F. Jahoor, P. Jones, and H. Pownall, Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of ???systemic steatosis???, Current Opinion in Lipidology, vol.15, issue.1, pp.59-67, 2004.
DOI : 10.1097/00041433-200402000-00011

A. Ogedegbe, D. Thomas, and A. Diehl, Hyperlactataemia syndromes associated with HIV therapy, The Lancet Infectious Diseases, vol.3, issue.6, pp.329-337, 2003.
DOI : 10.1016/S1473-3099(03)00654-6

E. Brunt, C. Janney, D. Bisceglie, A. Neuschwander-tetri, B. Bacon et al., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, The American Journal of Gastroenterology, vol.10, issue.9, pp.2467-2474, 1999.
DOI : 10.1016/S0168-8278(96)80234-0

P. Tien and C. Grunfeld, The fatty liver in AIDS, Semin Gastrointest Dis, vol.13, issue.1, pp.47-54, 2002.

J. Bauerle, R. Miquel, M. Laguno, J. Mallolas, J. Murillas et al., Hepatic steatosis with stavudine in HIV/hepatitis C virus co-infection, AIDS, vol.19, issue.13, pp.1441-1442
DOI : 10.1097/01.aids.0000180782.70988.18

T. Woreta, C. Sutcliffe, S. Mehta, T. Brown, Y. Higgins et al., Incidence and Risk Factors for Steatosis Progression in Adults Coinfected With HIV and Hepatitis C Virus, Gastroenterology, vol.140, issue.3, pp.809-817, 2011.
DOI : 10.1053/j.gastro.2010.11.052

J. Browning, L. Szczepaniak, R. Dobbins, P. Nuremberg, J. Horton et al., Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity, Hepatology, vol.83, issue.6, pp.401387-1395, 2004.
DOI : 10.1002/hep.20466

L. Martin-carbonero and V. Soriano, Interplay between hepatitis C, liver steatosis and antiretroviral therapy in HIV-infected patients, AIDS, vol.19, issue.6, pp.621-623
DOI : 10.1097/01.aids.0000163939.08811.10

L. Castera, C. Hezode, F. Roudot-thoraval, I. Lonjon, E. Zafrani et al., Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis, Gut, vol.53, issue.3, pp.420-424, 2004.
DOI : 10.1136/gut.2002.009936

D. Kumar, G. Farrell, C. Fung, and J. George, Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response, Hepatology, vol.94, issue.5, pp.1266-1272, 2002.
DOI : 10.1053/jhep.2002.36370

M. Loko, D. Salmon, P. Carrieri, M. Winnock, M. Mora et al., The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010, BMC Infectious Diseases, vol.33, issue.Suppl 2, p.303, 2006.
DOI : 10.1007/s10900-007-9083-3
URL : https://hal.archives-ouvertes.fr/pasteur-01070193

L. Adinolfi, M. Gambardella, A. A. Tripodi, M. Utili, R. Ruggiero et al., Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity, Hepatology, vol.33, issue.6, pp.1358-1364, 2001.
DOI : 10.1053/jhep.2001.24432

L. Castera, P. Chouteau, C. Hezode, E. Zafrani, D. Dhumeaux et al., Hepatitis C Virus-Induced Hepatocellular Steatosis, The American Journal of Gastroenterology, vol.116, issue.3, pp.711-715, 2005.
DOI : 10.1016/S0270-9139(03)80647-X

S. Clement and F. Negro, Hepatitis C virus: The viral way to fatty liver, Journal of Hepatology, vol.46, issue.6, pp.985-987, 2007.
DOI : 10.1016/j.jhep.2007.03.005

C. Hezode, F. Roudot-thoraval, E. Zafrani, D. Dhumeaux, and J. Pawlotsky, Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections, Journal of Viral Hepatitis, vol.122, issue.5, pp.455-458, 2004.
DOI : 10.1016/S0168-8278(00)00036-2

H. Patton, K. Patel, C. Behling, D. Bylund, L. Blatt et al., The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients, Journal of Hepatology, vol.40, issue.3, pp.40484-490, 2004.
DOI : 10.1016/j.jhep.2003.11.004

L. Rubbia-brandt, R. Quadri, K. Abid, E. Giostra, P. Male et al., Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3, Journal of Hepatology, vol.33, issue.1, pp.106-115, 2000.
DOI : 10.1016/S0168-8278(00)80166-X

I. Fortgang, P. Belitsos, R. Chaisson, and R. Moore, Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy, Am J Gastroenterol, vol.90, issue.9, pp.1433-1436, 1995.

M. Sulkowski, S. Mehta, R. Chaisson, D. Thomas, and R. Moore, Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir, AIDS, vol.18, issue.17, pp.2277-2284, 2004.
DOI : 10.1097/00002030-200411190-00008

C. Day and O. James, Steatohepatitis: a tale of two, pp.842-845, 1998.

J. Bauerle, M. Laguno, S. Mauss, J. Mallolas, J. Murillas et al., Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?, HIV Medicine, vol.61, issue.2, pp.135-139, 2005.
DOI : 10.1097/00002030-200204120-00001

. Martinez, Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals, BMC Research Notes, vol.5, issue.1
DOI : 10.1053/jhep.2002.35064
URL : https://hal.archives-ouvertes.fr/inserm-00715837